Biotech Growth Trust plc (The) (BIOG) Ordinary 25p
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
- Add to watchlist
- Create an alert
- This stock can be held in a
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
1,050.00p
1,060.00p
1,064.00p
1,126.75
1,054.00p
1,036.00p
715.00p
-8.41%
22.00p (2.13%) Previous:
22.00p
24,897
n/a
GBX
Price
-
Net Asset Value (NAV)
Performance
1 week 1W | 6.46% | 1 year 1Y | 31.75% |
---|---|---|---|
1 month 1M | 5.19% | 2 years 2Y | 19.5% |
3 months 3M | 9% | 3 years 3Y | 19.91% |
6 months 6M | 17.77% | 5 years 5Y | 33.42% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Trust Basics
Benchmark: | NASDAQ Biotechnology TR GBP |
---|---|
Annual management charge: | n/a |
Performance fee: | Yes |
Ongoing charge: | 1.52% |
Dividend yield: | n/a |
Dividend frequency: | None |
Total assets: | £371m |
Gross gearing: | 0% |
Market capitalisation:Market cap.: | £339m |
Shares in issue: | 32.89 million |
Legal structure | Closed Ended Investment Company |
Domicile: | United Kingdom |
ISIN | GB0000385517 |
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
Objective
NET ASSET VALUE (NAV)
Estimated NAV: | 1,126.75 |
---|---|
Latest actual NAV: | 1,128.76 |
Latest actual NAV date: | 15 July 2024 |
Premium/Discount: | -8.41% |
12m average Premium/Discount: | -7.35% |
NAV frequency: | Daily |
Security | Weight |
---|---|
Biogen Inc | 6.47% |
Janux Therapeutics Inc Ordinary Shares | 5.06% |
Regeneron Pharmaceuticals Inc | 4.80% |
Sarepta Therapeutics Inc | 4.59% |
Amgen Inc | 3.95% |
Avidity Biosciences Inc Ordinary Shares | 3.80% |
Scholar Rock Holding Corp | 3.53% |
Apellis Pharmaceuticals Inc | 3.45% |
Vaxcyte Inc Ordinary Shares | 3.43% |
Geron Corp | 3.22% |
Sector | Weight |
---|---|
Healthcare | 105.01% |
Country | Weight |
---|---|
United States | 98.84% |
China | 3.62% |
Canada | 1.79% |
Germany | 1.50% |
Key Dates
Launch date: | 23 June 1997 |
---|---|
Financial year end: | March |
Next AGM: | July 2025 |
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.